GO:0001772 immunological synapse: Components, Assembly and Research Methods, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0001772 immunological synapse is a cellular component defined as an area of close contact between a lymphocyte (T, B, or NK cell) and a target cell, formed by clustering of signaling and adhesion molecules and associated membrane rafts.
The immunological synapse facilitates lymphocyte activation, membrane transfer from target to lymphocyte, and in some cases killing of the target cell via secretory granules or death-pathway ligand-receptor interactions.
Key molecular players include TCR, MHC, CD28, CD80/86, LFA-1, ICAM-1, CD2, CD48, and CD99, which organize into supramolecular activation clusters (c-SMAC, p-SMAC).
Immunological synapse formation is critical for CAR-T cell function, and its impairment by tumor-derived metabolites or exhaustion limits immunotherapy efficacy.
Phase separation of chimeric antigen receptors and lipid switches in the synaptic membrane regulate synapse maturation and persistent cytotoxicity.
Research methods to study the immunological synapse include live-cell imaging, super-resolution microscopy, proteomics, and CRISPR-based genetic screens.

Description

The immunological synapse (GO:0001772) is a specialized cellular structure that forms at the interface between a lymphocyte and an antigen-presenting or target cell. It is defined as an area of close contact formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell, facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction. This structure is central to adaptive and innate immune responses, enabling precise communication between immune cells and their targets. Researchers study the immunological synapse to understand how T cells, B cells, and natural killer (NK) cells recognize and respond to antigens, and how defects in synapse formation contribute to cancer, autoimmunity, and immunodeficiency. Recent work has highlighted the role of the immunological synapse in CAR-T cell therapy, where synapse quality correlates with cytotoxic efficacy and persistence. Moreover, tumor cells can actively impair synapse formation through metabolites, providing a mechanism of immune evasion. The immunological synapse is not a static structure but a dynamic, highly organized assembly of receptors, adhesion molecules, and cytoskeletal elements that undergo continuous remodeling. Its study requires advanced imaging, proteomic, and genetic tools, and it represents a promising target for therapeutic intervention in cancer and immune disorders.

immunological synapse At A Glance

GO ID GO:0001772
GO term immunological synapse
Ontology cellular_component
Synonym c-SMAC, supramolecular activation cluster
Major function Facilitates lymphocyte activation, membrane transfer, and target cell killing through organized signaling and adhesion molecule clusters.
Cellular location Plasma membrane interface between lymphocyte and target cell.
Key molecules TCR, MHC, CD28, CD80/86, LFA-1, ICAM-1, CD2, CD48, CD99, and associated membrane rafts.
Related processes T cell activation, CAR-T cell cytotoxicity, immune evasion, and immunotherapy response.

What Is GO:0001772?

The immunological synapse (GO:0001772) is a cellular component defined as an area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell. It forms through the clustering of specific signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell. This structure facilitates activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.

Why Is immunological synapse Important in Cell Biology?

The immunological synapse is a fundamental structure for immune recognition and response, and its dysfunction is implicated in cancer, autoimmunity, and immunodeficiency. It is the primary site of T cell receptor signaling and costimulation, and its quality determines the outcome of immune responses, including CAR-T cell therapy efficacy. Understanding its molecular organization provides opportunities for therapeutic intervention, such as enhancing synapse formation to improve cancer immunotherapy or disrupting it to treat autoimmune diseases.
Central to T cell activation and adaptive immunity, as it organizes TCR signaling and costimulation.
Required for cytotoxic T lymphocyte and NK cell killing of target cells through directed secretion.
Dysregulated in cancer, where tumor cells impair synapse formation to evade immune attack.
Critical for CAR-T cell function; synapse maturation correlates with persistent cytotoxicity.
CD99 and CD2 enhance CAR-T cell efficacy via synapse remodeling.
Lipid composition and phase separation regulate synapse stability and signaling.
Involved in B cell activation and antibody responses.
Target for immunomodulatory therapies in autoimmunity and transplantation.
Studied using advanced imaging and CRISPR screens to identify novel regulators.
Provides a model for understanding cell-cell communication and membrane dynamics.

Structure and Composition of immunological synapse

Initial Contact and Adhesion Ring
In simple terms: The lymphocyte first touches the target cell, and adhesion molecules hold them together.
The initial contact between a lymphocyte and a target cell is mediated by adhesion molecules such as LFA-1 on the lymphocyte binding to ICAM-1 on the target cell. This interaction forms the peripheral supramolecular activation cluster (p-SMAC), which stabilizes the contact and allows for sustained signaling. The p-SMAC is characterized by a ring of integrins and is essential for synapse stability.
Central Supramolecular Activation Cluster (c-SMAC)
In simple terms: The center of the synapse concentrates the receptors that recognize antigen and send activation signals.
The central supramolecular activation cluster (c-SMAC) is enriched in T cell receptors (TCRs), costimulatory molecules such as CD28, and signaling kinases. This region is where antigen recognition and signal transduction occur, leading to lymphocyte activation. The c-SMAC forms through actin cytoskeleton reorganization and is maintained by continuous receptor recycling.
Membrane Rafts and Lipid Organization
In simple terms: Specialized patches of the cell membrane help gather signaling molecules together.
Membrane rafts are cholesterol- and sphingolipid-rich microdomains that concentrate signaling molecules at the immunological synapse. Lipid switches, such as changes in phosphatidylserine exposure, regulate the recruitment of signaling proteins and the stability of the synapse. These rafts are critical for efficient TCR signaling and synapse maturation.
Cytoskeletal Remodeling and Phase Separation
In simple terms: The cell's internal skeleton rearranges to shape the synapse, and some proteins form liquid-like droplets to organize signaling.
Actin cytoskeleton remodeling drives the formation and maintenance of the immunological synapse, including the movement of receptors into the c-SMAC. Recent studies have shown that phase separation of chimeric antigen receptors (CARs) promotes synapse maturation and persistent cytotoxicity, highlighting a biophysical mechanism for synapse organization. This phase separation is driven by multivalent interactions and is essential for CAR-T cell function.
Secretory Domain and Killing Machinery
In simple terms: The synapse directs toxic granules to kill the target cell when needed.
In cytotoxic lymphocytes, the immunological synapse includes a secretory domain where lytic granules are released toward the target cell. This directed secretion ensures efficient killing while minimizing damage to bystander cells. The centrosome reorients toward the synapse to facilitate granule delivery.

Key Genes Involved in GO:0001772 immunological synapse

The following genes encode key proteins that constitute or regulate the immunological synapse, and their study is essential for understanding synapse biology and developing immunotherapies.
GeneMajor RoleResearch Relevance
TCRAntigen recognition and signaling at c-SMACCentral to T cell activation; target for engineering.
CD28Costimulatory receptor binding CD80/86Enhances synapse formation and T cell activation.
CD80Ligand for CD28 on antigen-presenting cellsCostimulatory signal for T cell activation.
CD86Ligand for CD28 on antigen-presenting cellsCostimulatory signal for T cell activation.
LFA-1Integrin mediating adhesion to ICAM-1Forms p-SMAC; stabilizes synapse.
ICAM-1Adhesion ligand for LFA-1 on target cellsEssential for synapse stability.
CD2Adhesion and costimulatory molecule binding CD48Enhances CAR-T efficacy via synapse remodeling.
CD48Ligand for CD2 on target cellsModulates synapse formation.
CD99Adhesion molecule promoting synapse formationPotentiates CAR-T cell function.
ZAP-70Kinase downstream of TCRCritical for TCR signaling at synapse.
LATAdaptor protein in TCR signalingScaffolds signaling complexes at synapse.
ActinCytoskeletal componentDrives synapse assembly and receptor clustering.
CARChimeric antigen receptor in engineered T cellsPhase separation promotes synapse maturation.
PKCθKinase recruited to c-SMACRegulates NF-κB activation.
CD45Phosphatase regulating TCR signalingModulates synapse signaling thresholds.
CD3ζSignaling subunit of TCRTransmits activation signals.
F-actinFilamentous actinMaintains synapse architecture.

How Is immunological synapse Regulated?

The immunological synapse is dynamically regulated by multiple mechanisms. Lipid switches, including changes in phosphatidylserine and cholesterol content, modulate membrane raft organization and signaling. Phase separation of receptors such as CARs drives synapse maturation and persistent cytotoxicity. Tumor-derived metabolites, such as central nervous system-enriched metabolites, can impair synapse formation, providing a mechanism of immune evasion. Additionally, CD2 and CD99 expression levels regulate synapse remodeling and CAR-T cell exhaustion. These regulatory layers offer targets for therapeutic intervention.

immunological synapse and Human Disease

GeneDisease / BiologyPotential Experimental Model
CD99Cancer immunotherapy responseCD99 knockout or overexpression in CAR-T cells.
CD2T cell exhaustion and CAR-T efficacyCD2 knock-in or overexpression in T cells.
CARB cell malignanciesPhase separation mutants of CAR in primary T cells.
LFA-1Leukocyte adhesion deficiencyPoint mutations in ITGB2 gene in cell lines.
TCRAutoimmunity and immunodeficiencyTCR signaling mutants in Jurkat cells.
Cancer Immune Evasion
Tumor cells can impair immunological synapse formation through the secretion of central nervous system-enriched metabolites, thereby evading T cell-mediated killing. This mechanism highlights the synapse as a target for overcoming immunotherapy resistance.
CAR-T Cell Therapy
The quality of immunological synapse formation correlates with CAR-T cell efficacy. Phase separation of CARs promotes synapse maturation and persistent cytotoxicity, while CD99 and CD2 augmentation enhance CAR-T function via synapse remodeling and reduced exhaustion. These findings support engineering strategies to optimize synapse formation.
Autoimmunity and Immunodeficiency
Defects in immunological synapse components can lead to autoimmunity or immunodeficiency. For example, mutations affecting TCR signaling or adhesion molecules disrupt synapse stability and immune homeostasis. Understanding these defects informs diagnosis and targeted therapies.

From immunological synapse-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X regulate synapse formation?Knockout of gene X in primary T cells or Jurkat cells followed by imaging.
Does a point mutation in gene Y affect synapse stability?CRISPR point mutation knock-in in T cell lines.
Does overexpression of gene Z enhance CAR-T cytotoxicity?Overexpression of gene Z in CAR-T cells.
How does phase separation of CAR affect synapse maturation?Knock-in of phase separation mutants in CAR-T cells.
What is the role of lipid switches in synapse signaling?CRISPR knockout of lipid-modifying enzymes in T cells.
Can tumor metabolites impair synapse formation?Co-culture of tumor cells with T cells and metabolite treatment.

How to Study the immunological synapse Process

MethodWhat It MeasuresTypical Application
Live-cell imagingDynamics of synapse formation and receptor clusteringReal-time visualization in T cells.
Super-resolution microscopyNanoscale organization of synapse componentsc-SMAC and p-SMAC architecture.
ProteomicsProtein composition and modificationsIdentification of novel synapse proteins.
CRISPR screensGenes regulating synapse formationDiscovery of therapeutic targets.
Cytotoxicity assaysTarget cell killingCAR-T cell function.
Cytokine release assaysLymphocyte activationT cell effector function.
Calcium fluxSignaling activationTCR signaling strength.
Phase separation assaysBiomolecular condensate formationCAR synapse maturation.
Live-Cell Imaging and Super-Resolution Microscopy
Live-cell imaging and super-resolution microscopy allow visualization of immunological synapse formation in real time, including receptor clustering and cytoskeletal dynamics. These methods are essential for assessing synapse architecture and function.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can identify the molecular composition of the immunological synapse and post-translational modifications that regulate signaling. This approach reveals novel synapse components and signaling networks.
CRISPR Screens
Genome-wide CRISPR screens enable unbiased discovery of genes that regulate immunological synapse formation and function. Such screens have identified novel modulators of T cell activation and CAR-T efficacy.
Functional Assays
Cytotoxicity assays, cytokine release assays, and calcium flux measurements quantify lymphocyte activation and target cell killing following synapse formation. These functional readouts complement imaging and omics approaches.

How CRISPR Can Be Used to Study GO:0001772 immunological synapse

Knockout

CRISPR knockout of candidate genes in T cells or Jurkat cells can determine whether they are required for immunological synapse formation. For example, knockout of CD99 or CD2 reduces synapse stability and CAR-T efficacy. Knockout screens have identified novel regulators of synapse function.

Point Mutation

CRISPR point mutation knock-in allows precise modeling of disease-associated variants in synapse genes. For instance, mutations in ITGB2 (LFA-1) can be introduced to study leukocyte adhesion deficiency. This approach reveals how specific amino acid changes affect synapse assembly and signaling.

Knock-in

Knock-in of tagged or fluorescently labeled synapse proteins enables live-cell imaging and proteomic analysis. Tagged knock-in of TCR components or CARs can track their localization and dynamics at the synapse. This method is valuable for understanding molecular trafficking.

Overexpression

Overexpression of synapse-enhancing genes, such as CD2 or CD99, can boost CAR-T cell function by promoting synapse formation and reducing exhaustion. Overexpression models are useful for gain-of-function studies and therapeutic engineering.

How EDITGENE Supports immunological synapse Research

Researchers studying immunological synapse-related genes often need to determine whether a candidate gene is causally involved in synapse formation, stability, or function. EDITGENE provides comprehensive CRISPR-based services to accelerate this research, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for immunological synapse research.

Frequently Asked Questions About immunological synapse

The immunological synapse (GO:0001772) is an area of close contact between a lymphocyte and a target cell, formed by clustering of signaling and adhesion molecules, facilitating lymphocyte activation and target cell killing.
Key genes include TCR, CD28, CD80, CD86, LFA-1, ICAM-1, CD2, CD48, CD99, ZAP-70, LAT, and actin cytoskeleton components.
It facilitates lymphocyte activation, transfer of membrane from target to lymphocyte, and in some cases killing of the target cell through secretory granules or death-pathway ligand-receptor interactions.
It is organized into supramolecular activation clusters: c-SMAC enriched in TCR and costimulatory molecules, and p-SMAC containing adhesion molecules like LFA-1.
Synapse quality correlates with CAR-T efficacy; phase separation of CARs promotes synapse maturation, and CD99 or CD2 augmentation enhances CAR-T function.
Tumor cells can impair synapse formation via central nervous system-enriched metabolites, reducing T cell activation and killing.
Live-cell imaging, super-resolution microscopy, proteomics, CRISPR screens, and functional assays such as cytotoxicity and cytokine release.
Cancer immune evasion, autoimmunity, immunodeficiency, and CAR-T therapy resistance.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional studies of synapse genes.
Membrane rafts concentrate signaling molecules and lipid switches regulate synapse stability and signaling.

Conclusion

The immunological synapse (GO:0001772) is a dynamic cellular structure essential for lymphocyte activation and target cell killing. Its molecular organization, regulation by lipid switches and phase separation, and role in cancer immunotherapy make it a focal point for basic and translational research. Understanding synapse biology can lead to improved CAR-T therapies and new treatments for immune disorders.

References

  1. 1. Dustin ML. 2014. The immunological synapse.. Cancer Immunol Res 2(11):1023-33 PMID: 25367977
  2. 2. Li Y et al.. 2024. Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite.. Cancer Cell 42(6):985-1002.e18 PMID: 38821061
  3. 3. Chao Z et al.. 2025. Immunological synapse: structures, molecular mechanisms and therapeutic implications in disease.. Signal Transduct Target Ther 10(1):254 PMID: 40784895
  4. 4. Xu X et al.. 2024. Phase separation of chimeric antigen receptor promotes immunological synapse maturation and persistent cytotoxicity.. Immunity 57(12):2755-2771.e8 PMID: 39609126
  5. 5. Nam G et al.. 2025. CD99-mediated immunological synapse formation potentiates CAR-T cell function.. Nat Commun 16(1):7987 PMID: 40866332
  6. 6. Zhu Q et al.. 2025. CD2 augmentation enhances CAR-T-cell efficacy via immunological synapse remodeling and T-cell exhaustion mitigation.. Cell Mol Immunol 22(8):935-948 PMID: 40615696
  7. 7. Griffiths G et al.. 2024. Lipid switches in the immunological synapse.. J Biol Chem 300(7):107428 PMID: 38823638
  8. 8. Cassioli C et al.. 2019. A Ciliary View of the Immunological Synapse.. Cells 8(8) PMID: 31362462
Contact Us
*
*
*
*
How did you hear about us: